“Affordable therapies: Gaining a competitive advantage in Asia Pacific” is the first in a three-part series of series of thought leadership reports exploring strategic models for growth in Asia Pacific, the challenges and opportunities biopharma companies face, and what they can do to position themselves for success. 

This paper examines how companies can bridge the gap between affordability and patient need. It focuses on ways to transform development to increase efficiency and reduce costs; keys to successful development of biosimilars; and how to navigate the region’s complex regulatory environment to deliver value driven-products priced to meet market demands.